It also slows down the emptying of the stomach helping you to feel fuller for longer
Minnich A, Tian N, Byan L, Bilder G
Eficacia clnica En el amplio programa STEP (Semaglutide Treatment Effect in People with Obesity), donde los participantes recibieron 2,4 mg de semaglutida una vez por semana junto con apoyo en el estilo de vida, se logr una reduccin de peso promedio del 1517 % del peso corporal despus de 68 semanas de tratamiento, en comparacin con aproximadamente el 23 % en el grupo placebo (1)
The most frequently reported symptoms include: Nausea (especially during dose increases) Vomiting Diarrhea Constipation Abdominal discomfort Decreased appetite (an expected effect of the medication) For most patients, side effects stay in the tolerable range and tend to taper off as treatment continues
Clinical Trials: Retatrutide Results So Far The most compelling evidence for Retatrutides potential comes from a 2023 Phase 2 trial published in the New England Journal of Medicine